Standardization of tailor-made chemotherapy based on pharmacokinetics and pharmacogenomics
| Project/Area Number |
19590533
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Applied pharmacology
|
|---|
| Research Institution | Kyoto University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YANO Ikuko 京都大学, 薬学研究科, 准教授 (50273446)
YANAGIHARA Kazuhiro 京都大学, 医学研究科, 准教授 (70332731)
|
|---|
| Project Period (FY) |
2007 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2008: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2007: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Keywords | 臨床薬理学 / 薬理遺伝学 |
|---|
| Research Abstract |
Anti-neoplastics metabolized by liver has not only with narrow safety margin but also large inter-individual variation in pharmacokinetics. Dosing based on the knowledge of pharmacogenomics, drug interaction and pharmacokinetics are the most simple and reliable methods. We have conducted several investigator-initiated clinical pharmacology trial under approval of ethics committee of Kyoto University Hospital and searched for possibility for minimizing inter-individual variation in pharmacokinetics.
|
Report
(6 results)
Research Products
(110 results)
